OCT 28, 2016 11:46 AM PDT
Turning Temporary Cells Into Renewable Tumor-Killing Machines
WRITTEN BY: Kara Marker
3 10 545
The human immune system does have specially-designed cells for killing cancer cells, but they usually don’t live long enough to finish the job. A new study from the University of Cambridge focuses on enhancing their lifespan so cancer doesn’t stand a chance.
The Cytotoxic T Cell AKA The "Cancer Assassin." Credit: University of Cambridge
Cytotoxic CD8 T cells (Tc cells) are uniquely designed to participate in the virus- and cancer-targeting arm of the host defense system. They kill their targets by triggering apoptosis, also known as programmed cell suicide. Scientists from the University of Cambridge, in a new study published in the journal Nature, are improving upon existing Tc cell-based cancer treatments by increasing the time Tc cells thrive in the bloodstream.

"With a fairly trivial treatment of T-cells, we're able to change a moderate response to tumour growth to a much stronger response, potentially giving people a more permanent immunity to the tumours they are carrying,” said Cambridge Professor Randall Johnson. He’s talking about the anti-cancer technique that involves growing large populations of Tc cells in the lab, which are programmed to recognize and kill cancer cells before being reintroduced into the body. “This could make immunotherapy for cancer much more effective."

The technique is called “adoptive T cell immunotherapy,” and it’s essentially Tc cell bootcamp that maximizes the cells’ cancer-killing potential. The only problem is that Tc cells are short-lived; the majority of them don’t survive past three days post-reintroduction, almost certainly not enough time to destroy the entire tumor or population of tumors.

Johnson and the team used a compound called 2-hydroxyglutarate (2-HG) in their study to enhance the lifespan of Tc cells. While the compound is known to trigger abnormal cell growth in tumors, a different form of 2-HG actually plays a vital role in Tc cell function by triggering its memory state, where the cells can be renewed, live longer, and re-activate to enter the fight against cancer (or infection).

The researchers tested the rebirth of Tc cells by increasing levels of 2-HG in the lab. They quickly saw that more 2-HG in the Tc cells enabled the generation of cells that could live longer and destroy tumors much more effectively.

"In a sense, this means that rather than creating killer T-cells that are active from the start, but burn out very quickly, we are creating an army of 'renewable cells' that can stay quiet for a long time, but will go into action when necessary and fight tumour cells," Johnson said.

Thanks to these renewable cells, scientists have a new hope for the future of cancer immunotherapy, and it’s all based on the innate power of the human immune system’s own cells.
 


Sources: University of Cambridge, Cell Metabolism, Immunobiology: The Immune System in Health and Disease. 5th edition.
About the Author
  • I am a scientific journalist and enthusiast, especially in the realm of biomedicine. I am passionate about conveying the truth in scientific phenomena and subsequently improving health and public awareness. Sometimes scientific research needs a translator to effectively communicate the scientific jargon present in significant findings. I plan to be that translating communicator, and I hope to decrease the spread of misrepresented scientific phenomena! Check out my science blog: ScienceKara.com.
You May Also Like
MAR 29, 2018
Immunology
MAR 29, 2018
An Off Switch for Inflammation?
Regulating inflammation is vital for controlling various autoimmune and inflammatory diseases. Inflammation is important as a response to pathogenic invasi
APR 04, 2018
Immunology
APR 04, 2018
Why is Whooping Cough Back?
Pertussis, or whooping cough, is back, and it’s at least partly because individuals who were vaccinated in the early days of the whooping cough vacci
APR 11, 2018
Immunology
APR 11, 2018
Gene Editing Tools Reveal Two Key Genes Involved in Influenza Infection
Using CRISPR/Cas9 gene editing tools, researchers identified two genes responsible for suppressing the immune system and allowing the influenza virus to in
APR 26, 2018
Immunology
APR 26, 2018
A Daily Dose of Baking Soda to Treat Autoimmune Disease
A simple solution of baking soda and water could help people treat autoimmune diseases like rheumatoid arthritis, according to recent findings from scienti
JUN 21, 2018
Immunology
JUN 21, 2018
The Silver Tsunami: An Aging Immune System and Cancer
Why do cases of cancer become more common as we get older? Scientists interested in explaining the so-called “Silver Tsunami” phenomenon look t
JUL 09, 2018
Immunology
JUL 09, 2018
Protein Complex Determines the Fate of T cells
The protein complex mTORC1 has been shown to integrate metabolic and signaling activity to determine the fate of T cell lineage between alpha beta and gamma delta.
Loading Comments...